BOIRF (Boiron) Tariff Resilience Score: 0/10 (As of Jul. 01, 2026)


BOIRF Boiron SA BOIRF
62 GF Score
Price $31.90
GF Value $33.67
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Boiron Tariff Resilience Score?

Boiron has the Tariff Resilience Score of 0, which implies that the company might have .

Boiron has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Boiron might have .

Boiron  (OTCPK:BOIRF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Boiron Tariff Resilience Score Related Terms

BOIRF
62GF Score
Boiron SA BOIRF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boiron (BOIRF) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of $31.90 is trading 5.3% below its estimated GF Value™ of $33.67. GuruFocus considers Boiron to be Fairly Valued.

Key valuation signals for BOIRF:

  • Tariff Resilience Score: 0
  • GF Value™: $33.67 vs. price of $31.90 (5.3% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the BOIRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boiron Business Description

Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
62GF Score

Get the complete analysis for BOIRF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.90
Price
$33.67
GF Value